Mehanna, Hisham http://orcid.org/0000-0002-5544-6224
Gaunt, Piers
Kong, Anthony
Hartley, Andrew
Sanghera, Paul
Forster, Martin
Sen, Mehmet
Paleri, Vinidh
Fong, Charles
Geropantas, Dinos
Srinivasan, Devraj
Garikipati, Satya
Moleron, Rafael
Casswell, Georgina
Aynsley, Eleanor
Ward, Amy
O’Toole, Lorcan
Mirza, Arafat
Firth, Charlotte
Humphreys, Isla
Fulton-Lieuw, Tessa
Roques, Tom
Nankivell, Paul
Article History
Received: 26 September 2023
Accepted: 15 December 2023
First Online: 15 January 2024
Declarations
:
: Initial approval was gained from the NRES Committee West Midlands - Edgbaston on 27 November 2014 (Ref: 14/WM/1170). Approval in Ireland from the Clinical Research Ethics Committee of the Cork Teaching Hospitals was received on 08 September 2020 (Ref: ECM 5 (4) 25/07/19 and ECM 3 (mmm) 08/09/2020).
: Not applicable. No identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. The participant information materials and informed consent form are attached in Additional file InternalRef removed: Appendix 3
: HM received honoraria from AstraZeneca and travel support from Merck and has been on advisory boards for Eisai Inc., Nanobiotix, and Merck. AK has received fees for consulting, advisory, speaker’s roles, and/or research funding from PUMA BioTechnology, AstraZeneca, Merck, MSD, Bristol-Myers Squibb, and Avvinity Therapeutics. HM, PG, AH, PS, MF, MS, and VP received funds from Cancer Research UK and AstraZeneca to fund this study. All other authors declare that they have no competing interests.